Search Results
Aug 19, 2026, 03:51 ET Midea Partners with NARAP to Strengthen HVAC Skills Development in Nigeria
education. "For every training that we do, we try as much as possible not to do the same thing over and over again. As a brand, we invest heavily in R&D, which means we are constantly introducing innovations and technologies that keep us ahead of the market," he said.Beyond in-person technical
More news about: Midea Residential Air Conditioner
Aug 19, 2026, 03:30 ET HAVIT Showcases Its Decades of Audio Expertise at Gamescom 2026
advantage in developing professional gaming audio solutions.Supported by an in-house acoustic engineering team and comprehensive R&D capabilities, HAVIT continuously refines sound performance, wearing comfort, and user experience to meet the evolving needs of gamers worldwide, creating
More news about: HAVIT
Aug 19, 2026, 03:30 ET Au salon Gamescom 2026, HAVIT met en avant ses décennies d'expérience en technologie audio
solutions audio professionnelles destinées au jeu.S'appuyant sur une équipe interne d'ingénieurs en acoustique et sur des capacités de R & D complètes, HAVIT améliore sans cesse les performances sonores, le confort d'utilisation et l'expérience d'utilisation afin de répondre aux besoins
More news about: HAVIT
Aug 19, 2026, 03:00 ET QC Ware Announces 2026 Q2B Copenhagen Conference Focused on the Roadmap to Quantum Value in Europe and Beyond
sensing, communications, and security. Attendees can expect keynotes, industry case studies, and expert panel discussions on the leading edge of quantum R&D from some of the world's top businesses and institutions across government, academia, and Fortune 100 companies.The conference will open with
More news about: QC Ware Corp.
Aug 19, 2026, 02:57 ET Invitation to presentation of BioArctic's second quarter report for April - June 2026 on August 26 at 9:30 a.m. CEST
https://news.cision.com/bioarctic/r/invitation-to-presentation-of-bioarctic-s-second-quarter-report-for-april---june-2026-on-august-26-a,c4384796The following files are available for download:
More news about: BioArctic
Aug 19, 2026, 02:54 ET Invitation to presentation of BioArctic's second quarter report for April - June 2026 on August 26 at 9:30 a.m. CEST
https://news.cision.com/bioarctic/r/invitation-to-presentation-of-bioarctic-s-second-quarter-report-for-april---june-2026-on-august-26-a,c4384796The following files are available for download:
More news about: BioArctic
Aug 19, 2026, 02:47 ET Loyalist College advances medical imaging training with Sectra's Education Portal
https://news.cision.com/sectra/r/loyalist-college-advances-medical-imaging-training-with-sectra-s-education-portal,c4384631The following files are available for download:
More news about: Sectra
Aug 19, 2026, 02:46 ET SciBase: Interim report
https://news.cision.com/scibase/r/interim-report,c4384903The following files are available for download:
More news about: SciBase
Aug 19, 2026, 02:45 ET Loyalist College advances medical imaging training with Sectra's Education Portal
https://news.cision.com/sectra/r/loyalist-college-advances-medical-imaging-training-with-sectra-s-education-portal,c4384631The following files are available for download:
More news about: Sectra
Aug 19, 2026, 02:22 ET Changes in Nordea's Group Leadership Team
https://news.cision.com/nordea/r/changes-in-nordea-s-group-leadership-team,c4384988
More news about: Nordea
Aug 19, 2026, 02:03 ET Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026
execution. This was partially offset by higher cost of sales and higher R&D costs driven by advancing key pipeline assets. In the second quarter of 2026, adjusted EBITDA grew +6% CER, reflecting the normalization of cost phasing as R&D investment accelerated and the Q1 inventory build was a one-time
More news about: H. Lundbeck A/S
Aug 19, 2026, 02:00 ET Aily Labs Brings its Decision Intelligence to Google Cloud
decision-makers. A single interface, the Super Agent, coordinates thousands of specialized AI agents across finance, supply chain, manufacturing, R&D, and commercial operations.Pharmaceutical companies use Aily to accelerate clinical development, optimize regulatory submissions, improve capital
More news about: Aily Labs
Aug 19, 2026, 01:59 ET Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026
execution. This was partially offset by higher cost of sales and higher R&D costs driven by advancing key pipeline assets. In the second quarter of 2026, adjusted EBITDA grew +6% CER, reflecting the normalization of cost phasing as R&D investment accelerated and the Q1 inventory build was a one-time
More news about: H. Lundbeck A/S
Aug 19, 2026, 01:38 ET Lundbeckfond Invest A/S launches voluntary exchange offer for A-shares in H. Lundbeck A/S
https://news.cision.com/h--lundbeck-a-s/r/lundbeckfond-invest-a-s-launches-voluntary-exchange-offer-for-a-shares-in-h--lundbeck-a-s,c4385004The following files are available for download:
More news about: H. Lundbeck A/S
Aug 19, 2026, 01:33 ET Lundbeckfond Invest A/S launches voluntary exchange offer for A-shares in H. Lundbeck A/S
https://news.cision.com/h--lundbeck-a-s/r/lundbeckfond-invest-a-s-launches-voluntary-exchange-offer-for-a-shares-in-h--lundbeck-a-s,c4385004The following files are available for download:
More news about: H. Lundbeck A/S
Aug 19, 2026, 01:32 ET Flex LNG - Second Quarter 2026 Presentation
https://news.cision.com/flex-lng/r/flex-lng---second-quarter-2026-presentation,c4384941The following files are available for download:
More news about: Flex LNG
Aug 19, 2026, 01:15 ET Flex LNG - Second Quarter 2026 Earnings Release
https://news.cision.com/flex-lng/r/flex-lng---second-quarter-2026-earnings-release,c4384944The following files are available for download:
More news about: Flex LNG
Aug 18, 2026, 22:51 ET CHARBONE's Phase 1B Takes a Major Step Forward as Electrolyzer Arrives at Sorel-Tracy
https://news.cision.com/charbone-hydrogen-corporation/r/charbone-s-phase-1b-takes-a-major-step-forward-as-electrolyzer-arrives-at-sorel-tracy,c4384909
More news about: Charbone Hydrogen Corporation
Aug 18, 2026, 21:45 ET LG Display unveils FLiPP, achieving dream next-generation OLED technology
2,500 mm) substrates, to be divided and processed as half-cut substrates due to the limited size of FMM sticks. After a year of concentrated R&D, LG Display came up with FLiPP as a new OLED manufacturing paradigm. Unlike the FMM method, which may be compared to a stencil art technique where
More news about: LG Display
Aug 18, 2026, 21:00 ET Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
malignancies, today announced that the Company has been invited to participate in the Evercore 2nd China Biotech Summit, where it presented multiple key R&D highlights during a fireside chat. At the event, the Company presented updated clinical data for ATG–022 (CLDN18.2 antibody–drug conjugate [ADC]).
More news about: Antengene Corporation Limited
Aug 18, 2026, 21:00 ET LG ELECTRONICS BEGINS MASS PRODUCTION OF 5G SMART TELEMATICS SOLUTION FOR A PREMIUM EUROPEAN AUTOMAKER
Efficiency and SDV ReadinessNews SummaryLG Electronics has begun mass production of its next-generation 5G R16-based smart telematics solution and commenced deliveries to a premium European automaker, marking the solution's first deployment in a production vehicle
More news about: LG Electronics
Aug 18, 2026, 21:00 ET LG ELECTRONICS BEGINS MASS PRODUCTION OF 5G SMART TELEMATICS SOLUTION FOR A PREMIUM EUROPEAN AUTOMAKER
Efficiency and SDV ReadinessNews SummaryLG Electronics has begun mass production of its next-generation 5G R16-based smart telematics solution and commenced deliveries to a premium European automaker, marking the solution's first deployment in a production vehicle
More news about: LG Electronics
Aug 18, 2026, 20:15 ET CARsgen Therapeutics Announces 2026 Interim Results
lymphoma. An IIT has been initiated in 2026 for the treatment of R/R B-NHL.Other in vivo CAR T-cell products currently being developed include KJ-C2632 against BCMA/GPRC5D for R/R MM; KJ-C2633 against CD19/BCMA for R/R MM and autoimmune disease; KJ-C2634 against Claudin18.2 for
More news about: CARsgen Therapeutics
Aug 18, 2026, 18:20 ET /C O R R E C T I O N -- National Law Enforcement Officer Hall of Fame/
More news about: National Law Enforcement Officer Hall of Fame